Keiya Ozawa

598 total citations
38 papers, 443 citations indexed

About

Keiya Ozawa is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Keiya Ozawa has authored 38 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 15 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Keiya Ozawa's work include Virus-based gene therapy research (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Erythropoietin and Anemia Treatment (5 papers). Keiya Ozawa is often cited by papers focused on Virus-based gene therapy research (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Erythropoietin and Anemia Treatment (5 papers). Keiya Ozawa collaborates with scholars based in Japan, United States and United Kingdom. Keiya Ozawa's co-authors include Mitsuhiro Omine, Takashi Oyamada, Toyomi Kamesaki, Eiji Kajii, Akihiro Kume, Shigehiko Imagawa, Takashi Okada, Norio Suzuki, Tatsuya Nomoto and Masayuki Yamamoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Keiya Ozawa

33 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiya Ozawa Japan 13 186 164 126 71 63 38 443
Yutaka Negishi Japan 16 233 1.3× 65 0.4× 199 1.6× 42 0.6× 66 1.0× 37 576
Cécile Masson France 12 256 1.4× 55 0.3× 127 1.0× 115 1.6× 33 0.5× 34 524
Jürgen Groet United Kingdom 12 213 1.1× 243 1.5× 98 0.8× 63 0.9× 41 0.7× 15 502
Björn Jacobsson Sweden 11 158 0.8× 214 1.3× 44 0.3× 105 1.5× 73 1.2× 14 471
Nicole L. Hoppman United States 14 279 1.5× 173 1.1× 279 2.2× 78 1.1× 55 0.9× 62 704
Giuseppe Calabrese Italy 14 257 1.4× 135 0.8× 173 1.4× 189 2.7× 77 1.2× 45 711
Céline Villenet France 14 176 0.9× 79 0.5× 58 0.5× 50 0.7× 45 0.7× 31 472
Jonathan J. Waters United Kingdom 17 362 1.9× 127 0.8× 439 3.5× 58 0.8× 114 1.8× 32 1.0k
Lucrezia della Volpe Italy 5 266 1.4× 43 0.3× 98 0.8× 113 1.6× 61 1.0× 10 468
Marie‐Claire Malinge France 14 264 1.4× 72 0.4× 37 0.3× 66 0.9× 29 0.5× 20 678

Countries citing papers authored by Keiya Ozawa

Since Specialization
Citations

This map shows the geographic impact of Keiya Ozawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiya Ozawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiya Ozawa more than expected).

Fields of papers citing papers by Keiya Ozawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiya Ozawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiya Ozawa. The network helps show where Keiya Ozawa may publish in the future.

Co-authorship network of co-authors of Keiya Ozawa

This figure shows the co-authorship network connecting the top 25 collaborators of Keiya Ozawa. A scholar is included among the top collaborators of Keiya Ozawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiya Ozawa. Keiya Ozawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jong Wook, Jun Ho Jang, Shigeru Chiba, et al.. (2025). Romiplostim with ciclosporin A in patients with aplastic anaemia naïve to immunosuppressive therapy: A phase 2/3 study. British Journal of Haematology. 207(2). 582–590.
2.
Fujiwara, Shin‐ichiro, Kazuo Muroi, Raine Tatara, et al.. (2014). Intrathecal Administration of High-Titer Cytomegalovirus Immunoglobulin for Cytomegalovirus Meningitis. SHILAP Revista de lepidopterología. 2014. 1–3. 3 indexed citations
3.
Fukumura, Kazutaka, Yoshihiro Yamashita, Masahito Kawazu, et al.. (2013). STK10 missense mutations associated with anti-apoptotic function. Oncology Reports. 30(4). 1542–1548. 16 indexed citations
4.
Akimoto, Tetsu, Makoto Inoue, Toshimi Imai, et al.. (2011). Renal failure caused by plasma cell infiltration in multiple myeloma. Clinical and Experimental Nephrology. 15(4). 586–590. 7 indexed citations
5.
Iwamoto, Michiko, et al.. (2008). Leukemic cell infiltration into the large intestine in a patient with acute myelogenous leukemia. Gastrointestinal Endoscopy. 67(2). 353–354.
6.
Hirokawa, Makoto, Kenichi Sawada, Naohito Fujishima, et al.. (2008). Acquired pure red cell aplasia associated with malignant lymphomas: A nationwide cohort study in Japan for the PRCA Collaborative Study Group. American Journal of Hematology. 84(3). 144–148. 21 indexed citations
7.
Imagawa, Shigehiko, et al.. (2007). L-Arginine Administration Reverses Anemia Associated with Renal Disease. International Journal of Hematology. 86(2). 126–129. 5 indexed citations
9.
Takeda, Shin’ichi, Masafumi Takahashi, Hiroaki Mizukami, et al.. (2004). Successful Gene Transfer Using Adeno-Associated Virus Vectors into the Kidney: Comparison among Adeno-Associated Virus Serotype 1–5 Vectors in vitro and in vivo. Nephron Experimental Nephrology. 96(4). e119–e126. 48 indexed citations
10.
Muroi, Kazuo, et al.. (2003). Paraproteinemia After Hematopoietic Stem Cell Transplantation. Leukemia & lymphoma. 45(1). 135–137. 8 indexed citations
11.
Nagashima, Takeyuki, Yasuji Ueda, Yutaka Hanazono, et al.. (2003). New selective amplifier genes containing c-Mpl for hematopoietic cell expansion. Biochemical and Biophysical Research Communications. 303(1). 170–176. 5 indexed citations
12.
Imagawa, Shigehiko, Norio Suzuki, Harumi Y. Mukai, et al.. (2002). L-arginine rescues decreased erythropoietin gene expression by stimulating GATA-2With L-NMMA. Kidney International. 61(2). 396–404. 12 indexed citations
13.
Imagawa, Shigehiko, Norio Suzuki, Ken Ohmine, et al.. (2002). GATA Suppresses Erythropoietin Gene Expression through GATA Site in Mouse Erythropoietin Gene Promoter. International Journal of Hematology. 75(4). 376–381. 21 indexed citations
14.
Sato, Yuko, Tohru Izumi, Elizabeth M. Davis, et al.. (2002). t(1;3)(p36;p21) is a recurring therapy‐related translocation. Genes Chromosomes and Cancer. 34(2). 186–192. 8 indexed citations
15.
Muroi, Kazuo, et al.. (2002). Evaluation of engraftment by ABO genotypic analysis of erythroid burst-forming units after bone marrow transplantation. Leukemia Research. 26(1). 13–17. 5 indexed citations
16.
Maeda, Yoshikazu, Uichi Ikeda, Masahisa Shimpo, et al.. (2000). Adeno-Associated Virus-Mediated Vascular Endothelial Growth Factor Gene Transfer into Cardiac Myocytes. Journal of Cardiovascular Pharmacology. 36(4). 438–443. 12 indexed citations
17.
Jinbu, Yoshinori, et al.. (2000). Unusual Tumor Formation in the Tongue of an Acute Myelocytic Leukemia Patient: Report of a case.. Oral Medicine & Pathology. 5(1). 53–56. 2 indexed citations
18.
Ogasawara, Yoji, Masashi Urabe, Akihiro Kume, et al.. (1999). Efficient Production of Adeno‐associated Virus Vectors Using Split‐type Helper Plasmids. Japanese Journal of Cancer Research. 90(4). 476–483. 8 indexed citations
19.
Honda, Hiroaki, Keiya Ozawa, Yoshio Yazaki, & Hisamaru Hirai. (1997). Identification of PU.1 and Sp1 as Essential Transcriptional Factors for the Promoter Activity of MousetecGene. Biochemical and Biophysical Research Communications. 234(2). 376–381. 12 indexed citations
20.
Okano, Akira, Chieko Suzuki, Fumihiko Takatsuki, et al.. (1989). IN VITRO EXPANSION OF THE MURINE PLURIPOTENT HEMOPOIETIC STEM CELL POPULATION IN RESPONSE TO INTERLEUKIN 3 AND INTERLEUKIN 6. Transplantation. 48(3). 495–498. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026